07:00 , Jun 16, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Ophthalmic disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Ophthalmic disease Cataract FYVE and coiled-coil domain containing 1 (FYCO1) Genomewide association, mouse and human studies suggest FYCO1 mutations could help predict...